cryoablation + TQB2868 Injection + Catequentinib for cholangiocarcinoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 29 Sep 2026: Trial registered, NCT07846267

The trials

NCT07846267: Cryoablation Combined With Anlotinib Plus TQB2868 in Patients With Advanced Intrahepatic Cholangiocarcinoma

State
Not started
Phase
Phase 2
People
56 planned
Started
1 Oct 2026
Primary completion
1 Oct 2029
Arms
Cohort A, Cohort B
Results
None posted
  1. 29 Sep 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.